Skip to main content

Covid-19: Vaccine

Volume 677: debated on Tuesday 23 June 2020

Vaccine development is progressing well, with human clinical trials underway by both the University of Oxford and Imperial College London. We are also exploring how other vaccines, both from the UK and internationally, can be deployed here should they show promise.

Can my right hon. Friend reassure me, the House and my Welsh constituents in Montgomeryshire that if and when a vaccine for covid-19 is developed, it will be rolled out in a UK-wide partnership? Will he work with the devolved healthcare systems but ensure that the vaccine is UK-accessed?

Yes, of course. That is an incredibly important question for anybody living in Scotland, Wales or Northern Ireland, like my hon. Friend’s constituents. The vaccine programme is being taken forward on a UK-wide basis. Of course people living in the devolved nations should have access to vaccines according to a prioritisation that is clinical and not based on where people live. We will absolutely work with the devolved authorities on the delivery and deployment of that vaccine. Of course, we want the whole country to get the vaccines, if they become available, according to clinical priority.